Status:
COMPLETED
Development of a Celiac Safe Food Additive
Lead Sponsor:
Chalmers University of Technology
Collaborating Sponsors:
Gothia Forum - Center for Clinical Trial
Sahlgrenska University Hospital
Conditions:
Gluten Intolerance
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The goal of this clinical trial was to investigate if intestinal deamidation of gliadin from wheat bread could be hindered by adding a E304i/zinc additive. The study was a randomized double-blind 4-we...
Eligibility Criteria
Inclusion
- Signed informed consent
- Body mass index between 18.5 to 32
- Age between 18-50 years
- No tobacco use
Exclusion
- Celiac disease and other diagnosed enteropathies
- Gluten-free diet
- Dietary supplementation (minerals (calcium, zinc, vitamin D) and proteolytic enzymes, probiotics)
- Pregnancy or lactation
- Lack of suitability for participation in the study, for any reason, as judged by the medical doctor or the project PI.
- Withdrawn consent: Participant withdraws consent.
- Non-compliance: Participant fails repeatedly to comply with study protocol (diet, study visits and provide samples)
Key Trial Info
Start Date :
July 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 2 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06005376
Start Date
July 29 2020
End Date
November 2 2020
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chalmers University of Technology
Gothenburg, Sweden, 41296